A novel series of antagonists of the human A(2A) receptor have been identified and have been shown to display good potency and high degrees of selectivity over other receptor sub-types. Displaying in vivo potency in commonly used disease models and high oral bio-availability, this class of compounds may serve as clinically useful treatments for the relief of the symptoms associated with Parkinson's disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.03.142DOI Listing

Publication Analysis

Top Keywords

antagonists human
8
human a2a
8
a2a receptor
8
receptor highly
4
highly bio-available
4
bio-available pyrimidine-4-carboxamides
4
pyrimidine-4-carboxamides novel
4
novel series
4
series antagonists
4
receptor identified
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!